Exploration for Telomere related biomarker of adult gliomas
Project/Area Number |
26861171
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Neurosurgery
|
Research Institution | Osaka University |
Principal Investigator |
Arita Hideyuki 大阪大学, 医学系研究科, 特任助教(常勤) (60570570)
|
Research Collaborator |
ICHIMURA Koichi
YAMASAKI Kai
MATSUSHITA Yuko
NARITA Yoshitaka
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | Glioma / telomere / TERT / IDH / 神経膠腫 / 遺伝子変異 / IDH1/2 / 予後予測因子 / 分子分類 / 脳腫瘍 / 遺伝子 / IDH1 |
Outline of Final Research Achievements |
Gliomas are the most common primary brain tumors in adults. They are divided into several histological subtypes base on histology, but each subtype contains clinically diverse phenotypes. We hypothesized that telomere-related genes, mainly TERT promoter, may be a prognostic marker for this tumor. We conducted genetic analysis for a Japanese cohort, and investigated the relationships between genetic alteration and clinical courses. Our results indicated that TERT promoter mutations are useful to define glioma subclasses with different clinical courses in combination with IDH1/2 or MGMT methylation status.
|
Report
(4 results)
Research Products
(14 results)
-
[Journal Article] A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.2016
Author(s)
Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, Tanaka S, Mukasa A, Shirahata M, Shimizu S, Suzuki K, Saito K, Kobayashi K, Higuchi F, Uzuka T, Otani R, Tamura K, Sumita K, Ohno M, Miyakita Y, Kagawa N, Hashimoto N, Hatae R, Yoshimoto K, Shinojima N, Nakamura H, Kanemura Y, Okita Y, et al.
-
Journal Title
Acta Neuropathol Commun.
Volume: 4
Issue: 1
Pages: 79-79
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Presentation] Molecular classification based on IDH and TERT identified four clinically distinct subclasses: A study of Glioma Molecular Classification Consortium2016
Author(s)
Arita H, Yamasaki K, Kanemura Y, Mukasa A, Yoshimine T, Nagane M, Ueki K, Komori T, Nishikawa R, Narita Y, Ichimura K
Organizer
International Conference on Brain Tumor Research and Treatment (ICBTRT)
Place of Presentation
沖縄
Related Report
Int'l Joint Research
-
[Presentation] TERT promoter mutation is a poor prognostic marker for GBMs and interacts with MGMT methylation status.2016
Author(s)
Arita H, Yamasaki K, Nakamura T, Shirahata M, Kobayashi K, Tamura K,Fukai J,Terakawa Y, Mori K, Nakamura H, Yoshimoto K, Kanemura Y, Mukasa A, Yoshimine T, Nagane M, Ueki K, Komori T, Nishikawa R, Narita Y, Ichimura K
Organizer
21th Annual Scientific Meeting and Education day of Society for Neuro-Oncology
Place of Presentation
Scottsdale, AZ, USA
Related Report
Int'l Joint Research
-
[Presentation] 膠芽腫における分子マーカーの予後因子としての意義~国内多施設大規模コホートの解析からの報告2016
Author(s)
有田 英之, 山崎 夏維, 松下 裕子, 白畑 充章, 金村 米博, 吉本 幸司, 中村 英夫, 武笠 晃丈, 永根 基雄, 植木 敬介, 西川 亮, 成田 善孝, 市村 幸一, グリオーマ分子診断 共同研究グループ
Organizer
日本脳神経外科学会第75回学術総会
Place of Presentation
福岡
Related Report
-
[Presentation] 膠芽腫におけるTERTプロモーター変異とMGMTメチル化状態の予後因子としての意義2016
Author(s)
有田 英之, 山崎 夏維, 松下 裕子, 白畑 充章, 金村 米博, 吉本 幸司, 中村 英夫, 武笠 晃丈, 永根 基雄, 植木 敬介, 西川 亮, 成田 善孝, 市村 幸一, グリオーマ分子診断 共同研究グループ
Organizer
第34回日本脳腫瘍学会学術集会
Place of Presentation
甲府
Related Report
-
[Presentation] IDHとTERTによる成人神経膠腫の分子分類~国内多施設大規模コホートの解析からの追跡報告2015
Author(s)
有田 英之,山崎夏維,小林啓一,白畑充章,高見浩数,高柳俊作,中村大志,吉田俊,沖田典子,田村郁,深井順也,森鑑二,正札智子,児玉良典,森内秀祐,宮北 康二,大野 誠,田中將太,武笠 晃丈,橋本直哉,寺川雄三,露口尚弘,藤田浩二,友金祐介,埜中正博,金村米博,澁谷誠,鈴木博義,前原健寿,川原信隆,永根 基雄,植木敬介,西川亮,小森隆司,成田善孝,市村幸一
Organizer
第33回日本脳腫瘍学会学術集会
Place of Presentation
グランドプリンスホテル京都
Year and Date
2015-12-06
Related Report
-
[Presentation] Molecular classification based on IDH1/2 and TERT promoter well-defines subgroups with different outcome in adult diffuse gliomas: A report from Glioma Molecular Classification Consortium.2015
Author(s)
Arita H, Yamasaki K, Matushita Y, Nakamura T, Shirahata M, Tamura K, Terakawa Y, Fukai J, Mukasa A, Suzuki H, Shibuya M, Kanemura Y, Yoshimine T, Saito N, Nagane M, Ueki K, Komori T, Nishikawa R, Narita Y, Ichimura K
Organizer
20th annual scientific meeting and education day of the Societry for Neuro-Oncology
Place of Presentation
Marriott River Center Texas, USA
Year and Date
2015-11-19
Related Report
Int'l Joint Research
-
[Presentation] IDHとTERTによる成人神経膠腫の分子分類~国内多施設大規模コホートの解析より2015
Author(s)
有田 英之, 山崎 夏維, 松下 裕子, 中村 大志, 田村 郁, 白畑 充章, 武笠 晃丈, 金村 米博, 小森 隆司, 永根 基雄, 植木 敬介, 吉峰 俊樹, 西川 亮, 成田 善孝, 市村 幸一, グリオーマ分子診断 共同研究グループ
Organizer
一般社団法人日本脳神経外科学会 第74回学術総会
Place of Presentation
ロイトン札幌
Year and Date
2015-10-14
Related Report
-
-
-
-
-